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Studies in experimental diabetic rat attribute the acute 
reversible nerve conduction defect as well as the early 
structural abnormalities of the node of Ranvier and 
myelinated axons to changes in nerve metabolism 
secondary to hyperglycaemia and activation of the pol yo1 
pathway.’-8 The early readily reversible slowing of nerve 
conduction velocity in the diabetic rats correlates with 
a decrease in nerve Na,K-ATPase a ~ t i v i t y , ~  which induces 
a selective conduction block of large rapidly conducting 
fibres by inactivating voltage-dependent sodium chan- 
n e l ~ . ~  A further progressive impairment of nerve conduc- 
tion velocity correlates with the progressive development 
of axo-glial dysjunstion, a characteristic structural lesion 
of the paranodal region in experimental diabetic rats 
and diabetic human subjects.6,8,’0 This structural defect 
isassociated with an acutely irreversible marked reduction 
in nodal sodium permeability.” Impaired Na,K-ATPase 
activity and axo-glial dysjunction are normalized or 
prevented by aldose reductase inhibition in the diabetic 
rat,”,’* in whom axo-glial dysjunction shows a strong 
correlation with the slowed nerve conduction velocity.’* 
These data indicate that the nodal delay of the impulse 
propagation i s  associated with axo-glial dysjunction and 
is superimposed on the slowing of nerve conduction 
velocity related to abnormalities in nerve fibre metab- 
olism. 
The neuroanatomical abnormalities associated with 
peripheral polyneuropathy in diabetic human subjects 
are similar to those of the diabetic rat including axo- 
glial dysjunction.lo The mechanisms underlying the 
electrophysiological abnormalities in diabetic patients 
are less well defined, but it i s  believed that they include 
both metabolic and structural  component^.'^ The rapid 
improvement in nerve conduction velocity following 
strict glycaemic control probably reflects improvements 
in nerve metabo l i~m. ’~  
Fibre atrophy and progressive loss of myelinated 
fibres are the structural hallmarks of advanced diabetic 
neuropathy in  human^.'^,'^ Decreased fibre diameter 
has been suggested as the basis for nerve conduction 
slowing in human diabetic ne~ropathy . ’~  This laboratory 
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has previously demonstrated that the progressive loss of 
myelinated fibres correlates with a progressive decrease 
in evoked potential amplitude,16 and that the improve- 
ment in myelinated fibre density in sural nerve biopsies 
following aldose reductase inhibitor treatment correlates 
significantly with the improvement in sural evoked 
potential amplitude. 
However no light-microscopically identifiable lesions 
correlate with nerve conduction velocity or its improve- 
ment following metabolic interventions. 
In the present studies we examined sural nerve biopsies 
electron microscopically to determine if ultrastructural 
lesions such as axo-glial dysjunction and/or axonal 
atrophy might provide a structural basis for nerve 
conduction slowing in diabetic neuropathy. 
Twenty-seven patients with overt diabetic polyneuro- 
pathy participating in an aldose reductase inhibitor 
trial with the experimental drug Sorbinil underwent 
electrophysiological studies and sural nerve biopsies at 
the entry into the trial. After 1 year of the placebo- 
controlled study, 16 of these patients underwent renewed 
sural nerve conduction studies and a second biopsy. 
Antidromic sural nerve conduction velocity were 
measured using surface electrodes. Supramaximal stimuli 
of 0.2 ms duration was applied and compound action 
potentials were obtained using averaging technique. 
The sural nerve biopsies were examined electron 
microscopically and assessed as to the frequency of axo- 
glial dysjunction as previously described in detail.8 
Axonal atrophy was examined using three independent 
morphometric techniques: 
1 . electron-microscopic assessment of myelin/axon ratio; 
2. frequency of excessively wrinkled myelinated fibres 
examined from single teased fibres; 
3. internodal length/diameter ratio measured from single 
teased fibres.8,10 
Correlations between the baseline nerve conduction 
and morphometric data demonstrated highly significant 
negative correlations between nerve conduction velocity 
and the product of the natural logarithm of the frequency 
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of axo-glial dysjunction and the natural logarithm of the 
extent of axonal atrophy. These significant correlations 
remained unchanged regardless of how axonal atrophy 
was assessed; either as myelin/axon ratio, or excessive 
myelin wrinkling or internodal length/diameter ratio. 
These correlations are similar to those obtained in the 
diabetic rat, in whom nerve conduction velocity showed 
an exponential correlation with axo-glial dysjunction.'L 
Following 1 year of aldose reductase inhibition with 
Sorbinil, patients treated with active drug showed a 
significant improvement in sural nerve conducting velo- 
city (p  < 0.05), whereas placebo-treated patients showed 
a small but statistically significant decrease in nerve 
conduction velocity (p < 0.05). Morphometrically pati- 
ents treated with active drug showed improvements in 
axo-glial dysjunction (p  < 0.012) and in axonal atrophy 
whether this was measured as axon/myelin ratio 
(p < O.OOOl) ,  excessive myelin wrinkling (p  < O.OOOl) ,  
or internodal length/diameter ratio (p < 0.0000). Pla- 
cebo-treated patients showed no change in any of the 
morphometric parameters over the 1 year clinical trial 
period. 
The data of all patients who demonstrated a measurable 
nerve conduction velocity at baseline and follow-up 
were then used to calculate the change in nerve 
conduction velocity, and the change in magnitude of 
axo-glial dysjunction and axonal atrophy as measured 
by the three independent parameters. The change in 
nerve conduction velocity was correlated with the 
product of the nat6ral logarithm of the change in axo- 
glial dysjunction and that of axonal atrophy. These 
calculations revealed highly significant positive corre- 
lations between the change in nerve conduction velocity 
and that of axo-glial dysjunction and axonal atrophy 
suggesting that axo-glial dysjunction and axonal calibre 
are major determinants for nerve conduction velocity. 
The present data therefore suggest that specific struc- 
tural changes in peripheral nerve form the basis for nerve 
function as measured by electrophysiological means. 
Hence, evoked compound action potential appears to 
reflect the density of myelinated nerve fibres in diabetic 
nerve and the slowing of nerve conduction velocity in 
overt diabetic neuropathy appears to occur as a result 
of a combination of nodal delay of the impulse due to 
axo-glial dysjunction and slowing of the internodal 
electrical transmission secondary to axonal atrophy. 
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